Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | USPH U.S. Physical Therapy, Inc. | ABBV AbbVie |
|---|---|---|
| Price | $82.60 -3.7% | $259.93 -0.6% |
| StockIQ Score | 56C Moderate Risk: Medium | 48D+ Moderate Risk: High |
| Technical | 82A- | 41D |
| Fundamental | 51C- | 57C |
| Growth | 57C | 34F |
| Fair Value | 45D+ | 33F |
| News | 26F | 98A+ |
| Quality | 47D+ | 42D |
| Risk | 48D+ | 44D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
U.S. Physical Therapy (USPH) outperforms AbbVie (ABBV) in technical strength with a score of 82 versus 41. However, AbbVie scores higher in fundamentals (57 vs. 51) and valuation (33 vs. 45). Both share a "MODERATE" rating, but USPH leads in growth (57 vs. 34) and investor sentiment (56 vs. 48).
